Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/22/2026 07:15 PDT] DYN Expected to Trade Up After Bullish Patterns Develop
• [05/11/2026 10:29 PDT] DYN SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [05/06/2026 14:55 PDT] DYN SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [04/28/2026 10:29 PDT] DYN SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [04/21/2026 09:28 PDT] DYN, Expected to Trade Lower After Bearish Insider Trading
• [04/14/2026 09:26 PDT] DYN Expected to Trade Down After Bearish Patterns Develop
• [04/08/2026 10:29 PDT] DYN SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [04/02/2026 11:07 PDT] DYN SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/31/2026 10:29 PDT] DYN SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/31/2026 07:24 PDT] DYN Expected to Trade Down After Bearish Patterns Develop
• [03/25/2026 10:29 PDT] DYN SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.